Anzahl der Publikationen: 48
Zeitschriftenartikel
Thienel, Manuela ORCID: https://orcid.org/0000-0002-2471-5807; Müller-Reif, Johannes B. ORCID: https://orcid.org/0000-0003-3454-2396; Zhang, Zhe ORCID: https://orcid.org/0000-0002-1163-7897; Ehreiser, Vincent ORCID: https://orcid.org/0000-0002-8820-8839; Huth, Judith; Shchurovska, Khrystyna; Kilani, Badr ORCID: https://orcid.org/0000-0003-0230-094X; Schweizer, Lisa ORCID: https://orcid.org/0000-0002-1165-7804; Geyer, Philipp E. ORCID: https://orcid.org/0000-0001-7980-4826; Zwiebel, Maximilian ORCID: https://orcid.org/0000-0002-7005-5619; Novotny, Julia ORCID: https://orcid.org/0000-0002-0929-0273; Lüsebrink, Enzo ORCID: https://orcid.org/0000-0002-3214-5672; Little, Gemma ORCID: https://orcid.org/0000-0001-9810-4358; Orban, Martin ORCID: https://orcid.org/0000-0001-9830-1941; Nicolai, Leo ORCID: https://orcid.org/0000-0003-0776-5885; El Nemr, Shaza ORCID: https://orcid.org/0000-0003-4542-693X; Titova, Anna ORCID: https://orcid.org/0009-0005-7412-7447; Spannagl, Michael; Kindberg, Jonas ORCID: https://orcid.org/0000-0003-1445-4524; Evans, Alina L. ORCID: https://orcid.org/0000-0003-0513-4887; Mach, Orpheus ORCID: https://orcid.org/0000-0002-7092-7050; Vogel, Matthias ORCID: https://orcid.org/0009-0002-1563-4519; Tiedt, Steffen ORCID: https://orcid.org/0000-0002-8817-8457; Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034; Kessler, Barbara; Dueck, Anne ORCID: https://orcid.org/0000-0002-7956-6327; Friebe, Andrea; Jørgensen, Peter Godsk ORCID: https://orcid.org/0000-0002-1217-8944; Majzoub-Altweck, Monir; Blutke, Andreas; Polzin, Amin ORCID: https://orcid.org/0000-0002-5891-9672; Stark, Konstantin; Kääb, Stefan ORCID: https://orcid.org/0000-0001-8824-3581; Maier, Doris ORCID: https://orcid.org/0000-0002-3261-2381; Gibbins, Jonathan M.; Limper, Ulrich ORCID: https://orcid.org/0000-0001-9927-4180; Frobert, Ole ORCID: https://orcid.org/0000-0002-5846-345X; Mann, Matthias ORCID: https://orcid.org/0000-0003-1292-4799; Massberg, Steffen ORCID: https://orcid.org/0000-0001-7387-3986 und Petzold, Tobias ORCID: https://orcid.org/0000-0001-7805-5632
(2023):
Immobility-associated thromboprotection is conserved across mammalian species from bear to human.
In: Science, Bd. 380, Nr. 6641: S. 178-187
Duan, Rundan; Goldmann, Luise; Brandl, Richard; Spannagl, Michael; Weber, Christian; Siess, Wolfgang und Hundelshausen, Philipp von
(24. September 2021):
Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time.
In: Frontiers in Cardiovascular Medicine, Bd. 8, 749022
[PDF, 2MB]
Pekrul, Isabell; Pfrepper, Christian; Calatzis, Geli; Giebl, Andreas; Siegemund, Annelie; Grützner, Stefanie und Spannagl, Michael
(2021):
Approximation of emicizumab plasma levels in emergency situations. A practical approach.
In: Haemophilia, Bd. 27, Nr. 2, E214-E220
Petzold, Tobias; Thienel, Manuela; Dannenberg, Lisa; Mourikis, Philipp; Helten, Carolin; Ayhan, Aysel; M'Pembele, Rene; Achilles, Alina; Trojovky, Kajetan; Konsek, Daniel; Zhang, Zhe; Regenauer, Ron; Pircher, Joachim; Ehrlich, Andreas; Luesebrink, Enzo; Nicolai, Leo; Stocker, Thomas J.; Brandl, Richard; Roeschenthaler, Franz; Strecker, Jan; Saleh, Inas; Spannagl, Michael; Mayr, Christoph H.; Schiller, Herbert B.; Jung, Christian; Gerdes, Norbert; Hoffmann, Till; Levkau, Bodo; Hohlfeld, Thomas; Zeus, Tobias; Schulz, Christian; Kelm, Malte und Polzin, Amin
(2020):
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
In: Circulation Research, Bd. 126, Nr. 4: S. 486-500
Goldmann, Luise; Duan, Rundan; Kragh, Thorsten; Wittmann, Georg; Weber, Christian; Lorenz, Reinhard; Hundelshausen, Philipp von; Spannagl, Michael und Siess, Wolfgang
(2019):
Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?
In: Blood Advances, Bd. 3, Nr. 23: S. 4021-4033
Nowak-Goettl, Ulrike; Miesbach, Wolfgang; Koscielny, Jürgen; Dempfle, Carl-Erik; Maegele, Marc; Depka Prondzinski, Mario von; Westrup, Dagmar und Spannagl, Michael
(2019):
Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring.
In: Hamostaseologie, Bd. 39, Nr. 4: S. 326-338
Denzinger, Viola; Busygina, Kristina; Jamasbi, Janina; Pekrul, Isabell; Spannagl, Michael; Weber, Christian; Lorenz, Reinhard und Siess, Wolfgang
(2019):
Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
In: Thrombosis and Haemostasis, Bd. 119, Nr. 3: S. 397-406
Arakawa, Akiko; Vollmer, Sigrid; Besgen, Petra; Galinski, Adrian; Summer, Burkhard; Kawakami, Yoshio; Wollenberg, Andreas; Dornmair, Klaus; Spannagl, Michael; Ruzicka, Thomas; Thomas, Peter und Prinz, Jörg C.
(2018):
Unopposed IL-36 Activity Promotes Clonal CD4(+) T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis.
In: Journal of Investigative Dermatology, Bd. 138, Nr. 6: S. 1338-1347
Bietenbeck, Andreas; Geilenkeuser, Wolf J.; Klawonn, Frank; Spannagl, Michael; Nauck, Matthias; Petersmann, Astrid; Thaler, Markus A.; Winter, Christof und Luppa, Peter B.
(2018):
External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact.
In: Clinical Chemistry and Laboratory Medicine, Bd. 56, Nr. 8: S. 1238-1250
Kellermair, Jörg; Ott, Helmut W.; Spannagl, Michael; Tomasits, Josef; Kammler, Jürgen; Blessberger, Hermann; Reiter, Christian und Steinwender, Clemens
(2018):
Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis.
In: Clinical and Applied Thrombosis-Hemostasis, Bd. 24, Nr. 3: S. 496-501
[PDF, 355kB]
Frietsch, Thomas; Thomas, Daffyd; Schöler, Michael; Fleiter, Birgit; Schipplick, Martin; Spannagl, Michael; Knels, Ralf und Nguyen, Xuan
(2017):
Administration Safety of Blood Products - Lessons Learned from a National Registry for Transfusion and Hemotherapy Practice.
In: Transfusion Medicine and Hemotherapy, Bd. 44, Nr. 4: S. 240-254
Koscielny, Jürgen; Heymann, Christian von; Zeymer, Uwe; Cremer, Jochen; Spannagl, Michael; Labenz, Joachim; Giannitsis, Evangelos und Goss, Franz
(2017):
Duale antithrombozytäre Therapie – Perioperativ absetzen oder weiterführen?
In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 16: S. 1223-1230
Blüm, Philipp; Pircher, Joachim; Merkle, Monika; Czermak, Thomas; Ribeiro, Andrea; Mannell, Hanna; Krötz, Florian; Hennrich, Alexander; Spannagl, Michael; Köppel, Simone; Gaitzsch, Erik und Wörnle, Markus
(2017):
Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C.
In: Cellular & Molecular Immunology, Bd. 14, Nr. 12: S. 986-996
Raziorrouh, Bijan; Heeg, Malte; Kurktschiev, Peter; Schraut, Winfried; Zachoval, Reinhart; Wendtner, Clemens; Wächtler, Martin; Spannagl, Michael; Denk, Gerald; Ulsenheimer, Axel; Bengsch, Bertram; Pircher, Hanspeter; Diepolder, Helmut M.; Grüner, Norbert H. und Jung, Maria-Christina
(2014):
Inhibitory Phenotype of HBV-Specific CD4⁺ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules.
In: PLOS ONE
9(8), e105703
[PDF, 1MB]
Ulsenheimer, Axel; Paranhos-Baccala, Glaucia; Komurian-Pradel, Florence; Raziorrouh, Bijan; Kurktschiev, Peter; Diepolder, Helmut M.; Zachoval, Reinhard; Spannagl, Michael; Jung, Maria-Christina und Grüner, Norbert H.
(2013):
Lack of variant specific CD8+T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C.
In: Virology Journal
10:295
[PDF, 606kB]
Klein, Christoph L.; Marki-Zay, János; Corbisier, Philippe; Gancberg, David; Cooper, S.; Gemmati, Donato; Halbmayer, Walter-Michael; Kitchen, Steve; Melegh, Béla; Neumaier, Michael; Oldenburg, Johannes; Opplinger Leibundgut, Elisabeth; Reitsma, Pieter H.; Rieger, Sandra; Schimmel, Heinz G.; Spannagl, Michael; Tordai, Attilia; Tosetto, Alberto; Visvikis, Sophie; Zadro, Renata und Mannhalter, Christine
(2005):
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
In: Clinical Chemistry and Laboratory Medicine, Bd. 43, Nr. 8: S. 862-868
[PDF, 284kB]
Siebeck, Matthias; Cheronis, J. C.; Fink, Edwin; Kohl, Jacek; Spies, Bernd; Spannagl, Michael; Jochum, Marianne und Fritz, Hans
(1994):
Dextran sulfate activates the contact system and mediates arterial hypotension via B2 kinin receptors.
In: Journal of applied physiology, Bd. 77: S. 2675-2680
[PDF, 1MB]
Siebeck, Matthias; Cheronis, John C.; Fink, Edwin; Kohl, Jacek; Spies, Bernd; Spannagl, Michael; Jochum, Marianne und Fritz, Hans
(1994):
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors.
In: Journal of Applied Physiology, Bd. 77, Nr. 6: S. 2675-2680
[PDF, 1MB]
Siebeck, Matthias; Fink, Edwin; Weipert, Joachim; Jochum, Marianne; Fritz, Hans; Spannagl, Michael; Kroworsch, Peter; Shimamoto, Kazuaki und Schweiberer, Leonhard
(Februar 1993):
Inhibition of Plasma Kallikrein with Aprotinin in porcine endotoxin Shock.
In: The Journal of Trauma-Injury Infection & Critical Care, Bd. 34, Nr. 2: S. 193-198
[PDF, 1MB]
Dietrich, W.; Mossinger, H.; Spannagl, Michael; Jochum, Marianne; Wendt, P.; Baranky, A.; Meisner, H und Richter, J. A.
(1993):
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
In: Journal of vascular surgery, Bd. 105: S. 712-720
[PDF, 7MB]
Nast-Kolb, Dieter; Waydhas, Christian; Jochum, Marianne; Duswald, Karl-Heimo; Machleidt, W.; Spannagl, Michael; Schramm, Wolfgang; Fritz, Hans und Schweiberer, Leonhard
(1992):
Biochemische Faktoren als objektive Parameter zur Prognoseabschätzung beim Polytrauma.
In: Der Unfallchirurg, Bd. 95, Nr. 2: S. 59-66
[PDF, 1MB]
Hoffmann, H.; Siebeck, Matthias; Spannagl, Michael; Weipert, J.; Geiger, R.; Jochum, Marianne und Fritz, Hans
(1990):
Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.
In: American review of respiratory diseases, Bd. 142, Nr. 4: S. 782-788
[PDF, 1MB]
Buchbeitrag
Nast-Kolb, Dieter; Waydhas, Christian; Jochum, Marianne; Spannagl, Michael; Machleidt, W.; Duswald, Karl-Heimo und Schweiberer, Leonhard
(1993):
Diagnostic role of new mediators and markers of inflammation in multiple injured patients.
In: Faist, E.; Meakins, J. und Schildberg, F. W. (Hrsg.):
Host Defence Dysfunction in Trauma, Shock and Sepsis. Berlin, Heidelberg: Springer. S. 221-227
[PDF, 1MB]
Dietrich, W.; Spannagl, Michael; Jochum, Marianne; Wendt, P.; Baranky, A. und Richter, J. A.
(1991):
Investigation on the mechanisms of action of aprotinin in cardiac surgery.
In: Friedel, N.; Hetzer, P. und Royston, D. (Hrsg.):
Blood Use in Cardiac Surgery. Darmstadt: Steinkopff. S. 232-239
[PDF, 1MB]
Dietrich, W.; Baranky, A.; Wendt, P.; Sternberger, A.; Blümel, G.; Spannagl, Michael; Jochum, Marianne und Richter, J. A.
(1988):
Fibrinolysis caused by cardio-pulmonary bypass and shed mediastinal blood retransfusion. Is it of clinical relevance?
In: Hörl, Walter H. und Heidland, A. (Hrsg.):
Proteases. Potential Role in Health and Disease. Bd. 2. New York: Plenum Press. S. 405-410
[PDF, 984kB]
Konferenzbeitrag
Siebeck, Matthias; Spannagl, Michael; Hoffmann, H. und Fink, Edwin
(1992):
Effects of protease inhibitors in experimental septic shock.
International Conference "Kinin 91 Munich, München, 8. - 14. September 1991.
International Conference Kinin (Hrsg.),
In: Recent Progress on Kinins, Agents and actions Suppl.
Bd. 38/III
S. 421-427
[PDF, 505kB]
Diese Liste wurde am
Sat Dec 21 18:11:40 2024 CET
erstellt.